Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Often used for:
Myelofibrosis, Certain relapsed cancers
Ruxolitinib is a type of medicine called a targeted therapy. This medicine is a tyrosine kinase inhibitor. It acts to block certain cell signals to help keep cells from growing.
Ruxolitinib may be used in combination with other medicines. This medicine is usually taken twice a day.
Patients will have regular blood draws to check blood counts and monitor liver and kidney function. The dose of ruxolitinib may change based on results of lab tests.
May be taken as a tablet by mouth
Not all patients who take ruxolitinib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Be sure to discuss these and other recommendations with your doctor or pharmacist.